Premium
Positive margins after nephron‐sparing surgery for renal cell carcinoma: long‐term follow‐up of patients on active surveillance
Author(s) -
LopezCostea Miguel A.,
Fumadó Lluís,
Lorente David,
Riera Luis,
Miranda Eladio Franco
Publication year - 2010
Publication title -
bju international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.773
H-Index - 148
eISSN - 1464-410X
pISSN - 1464-4096
DOI - 10.1111/j.1464-410x.2009.09174.x
Subject(s) - medicine , chromophobe cell , nephrectomy , renal cell carcinoma , surgery , papillary renal cell carcinomas , kidney cancer , clear cell carcinoma , stage (stratigraphy) , clear cell , carcinoma , radiology , kidney , paleontology , biology
Study Type – Therapy (case series)
Level of Evidence 4 OBJECTIVE To analyse our long‐term oncological outcomes with active surveillance in patients with positive surgical margins (PSMs) after nephron‐sparing surgery (NSS) for renal cell carcinoma (RCC), as this situation is a difficult therapeutic dilemma. PATIENTS AND METHODS We performed open NSS for renal masses with frozen‐section analysis of any suspicious zone of the surgical bed, followed by extensive argon‐beam coagulation. In patients where the final histopathological examination of the renal mass revealed PSMs, follow‐up consisted of computed tomography (CT) every 6 months in the first 2 years and then annually up to 5 years, and thereafter we alternated ultrasonography with CT. RESULTS From 1995 to 2003 we had 11 cases of microscopic definitive PSMs after NSS for RC C . Two patients required nephrectomy (one for postoperative bleeding and another as an elective procedure), so nine were followed. These patients were either operated under elective (seven) or imperative (two) conditions. The histological subtype was clear cell carcinoma in three, papillary in two, chromophobe in two and hybrid oncocytic RCC in two, with a Furhman grade of 2 in six and 3 in three. The mean size was 31.4 mm, and the stage was pT1a in six, pT1b in one and pT3a in two. After a median follow‐up of 80.5 months, there was no local recurrence or distant progression. CONCLUSIONS In our experience, microscopic PSMs in NSS specimens can be managed conservatively with active surveillance, achieving excellent results and avoiding extensive reoperation without compromising long‐term oncological outcomes.